Relation of platelet count to bleeding and vascular complications in patients undergoing coronary angiography

Param Vidwan1, Seonjoo Lee, Joseph S Rossi

  • 1Division of Cardiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Insights

Higher platelet counts increase the risk of bleeding and vascular complications in patients undergoing coronary angiography. This study found baseline platelet count to be a significant independent risk factor for these adverse events.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Hematology

Background:

  • Vascular and bleeding complications post-coronary angiography carry significant risks.
  • Limited data exist on the association between platelet count and these complications.

Purpose of the Study:

  • To investigate the relationship between baseline platelet count and the occurrence of bleeding or vascular complications in patients undergoing coronary angiography.

Main Methods:

  • Retrospective cohort analysis of 3,466 adult patients undergoing coronary angiography.
  • Data collected over a 2-year period at a single institution.
  • Complications defined by American College of Cardiology CathPCI Registry criteria.

Main Results:

  • A total of 143 complications (4.2%) were observed.
  • The risk of complications significantly increased with higher platelet counts.
  • Increasing platelet count, age, and percutaneous coronary intervention were independent predictors of complications.

Conclusions:

  • Baseline platelet count is a strong and independent risk factor for bleeding and vascular complications in patients undergoing coronary angiography.
  • Higher platelet levels necessitate careful consideration for risk stratification.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...